Hitachi awaits news on nuclear options
Food and Drug Administration clearance is imminent for several advanced gamma camera options developed by Hitachi Medical Systems America. The Twinsburg, OH, vendor has already received 510(k) clearance for a 5/8-inch crystal option, and is
Food and Drug Administration clearance is imminent for several advanced gamma camera options developed by Hitachi Medical Systems America. The Twinsburg, OH, vendor has already received 510(k) clearance for a 5/8-inch crystal option, and is awaiting the agencys word on nonuniform attenuation correction and coincidence detection options, according to Gary Enos, general manager of the unit.
The upgrades are Hitachis final touches that will make its premium SpectraDigital V250DSP camera a full-featured system capable of high-energy imaging. Hitachi will highlight the options at next months Society of Nuclear Medicine meeting in Los Angeles.
Hitachi will also have its hands full explaining the nuclear medicine units direction in light of the companys new relationship with ADAC Laboratories of Milpitas, CA. Earlier this month, Hitachi announced that it would halt development of new gamma cameras in favor of distributing ADAC systems in Japan (SCAN 5/12/99). Hitachi is reviewing its nuclear business in light of the ADAC relationship, Enos said.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
